文献速递妇科

主观评估与IOTA ADNEX模型在乳腺癌病史患者附件肿块评估中的应用

Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

本回顾性单中心研究纳入2013至2020年间因附件肿块手术的202例乳腺癌病史患者,评估主观评估与ADNEX模型鉴别良恶性及转移性与原发性附件肿瘤的性能。两者鉴别良恶性准确性相似(89.6% vs 89.1%),鉴别转移性与原发性肿瘤准确性亦相似(82.7% vs 81.2%),但后者敏感性均较低。

要点

  • 主观评估鉴别良恶性附件肿块的敏感性93.6%、特异性84.9%、准确性89.6%。
  • ADNEX模型鉴别良恶性敏感性98.2%高于主观评估,特异性78.5%较低,准确性89.1%相似。
  • 两者鉴别转移性与原发性肿瘤准确性相似,但敏感性均低(51.5% vs 63.6%)。

核心结论

  • 在乳腺癌病史患者中,主观评估与ADNEX模型鉴别附件肿块良恶性的性能相对相似。
  • 两者鉴别转移性与原发性肿瘤的准确性和特异性均良好,但敏感性低。

研究设计与样本

  • 回顾性单中心研究,纳入2013至2020年间因附件肿块接受手术的乳腺癌病史患者202例。
  • 所有患者均接受经阴道或经直肠超声标准化检查,调取存档超声报告分析原检查者的具体诊断。
  • ADNEX模型风险为前瞻性计算,以最高相对风险将肿块归入良性、交界性、原发性I期、原发性II-IV期或转移性卵巢癌五类之一。
  • 以最终组织学为参考标准,评估主观评估与ADNEX模型鉴别良恶性及原发与转移性附件肿瘤的性能。

主要发现

  • 组织学显示良性肿块93/202(46.0%),原发性恶性肿瘤76/202(37.6%,含4例交界性和72例浸润性肿瘤),转移性肿瘤33/202(16.3%)。
  • 原超声检查者正确分类良性肿块79/93(84.9%)、原发性附件恶性肿瘤72/76(94.7%)、转移性肿瘤30/33(90.9%)。
  • 鉴别良恶性时,主观评估敏感性93.6%、特异性84.9%、准确性89.6%;ADNEX模型敏感性98.2%更高、特异性78.5%更低,准确性89.1%相似。
  • 鉴别转移性与原发性肿瘤(含良性、交界性和浸润性肿瘤)时,主观评估敏感性51.5%、特异性88.8%、准确性82.7%;ADNEX模型敏感性63.6%、特异性84.6%、准确性81.2%相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the performance of subjective assessment and the Assessment of Different NEoplasias in the adneXa (ADNEX) model in discriminating between benign and malignant adnexal tumors and between metastatic and primary adnexal tumors in patients with a personal history of breast cancer. METHODS: This was a retrospective single-center study including patients with a history of breast cancer who underwent surgery for an adnexal mass between 2013 and 2020. All patients had been examined with transvaginal or transrectal ultrasound using a standardized examination technique and all ultrasound reports had been stored and were retrieved for the purposes of this study. The specific diagnosis suggested by the original ultrasound examiner in the retrieved report was analyzed. For each mass, the ADNEX model risks were calculated prospectively and the highest relative risk was used to categorize each into one of five categories (benign, borderline, primary Stage I, primary Stages II-IV or metastatic ovarian cancer) for analysis of the ADNEX model in predicting the specific tumor type. The performance of subjective assessment and the ADNEX model in discriminating between benign and malignant adnexal tumors and between primary and metastatic adnexal tumors was evaluated, using final histology as the reference standard. RESULTS: Included in the study were 202 women with a history of breast cancer who underwent surgery for an adnexal mass. At histology, 93/202 (46.0%) masses were benign, 76/202 (37.6%) were primary malignancies (four borderline and 72 invasive tumors) and 33/202 (16.3%) were metastases. The original ultrasound examiner classified correctly 79/93 (84.9%) benign adnexal masses, 72/76 (94.7%) primary adnexal malignancies and 30/33 (90.9%) metastatic tumors. Subjective ultrasound evaluation had a sensitivity of 93.6%, specificity of 84.9% and accuracy of 89.6%, while the ADNEX model had higher sensitivity (98.2%) but lower specificity (78.5%), with similar accuracy (89.1%), in discriminating between benign and malignant ovarian masses. Subjective evaluation had a sensitivity of 51.5%, specificity of 88.8% and accuracy of 82.7% in distinguishing metastatic and primary tumors (including benign, borderline and invasive tumors), and the ADNEX model had a sensitivity of 63.6%, specificity of 84.6% and similar accuracy (81.2%). CONCLUSIONS: The performance of subjective assessment and the ADNEX model in discriminating between benign and malignant adnexal masses in this series of patients with history of breast cancer was relatively similar. Both subjective assessment and the ADNEX model demonstrated good accuracy and specificity in discriminating between metastatic and primary tumors, but the sensitivity was low. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Pozzati F, Sassu CM, Marini G, et al. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer. Ultrasound Obstet Gynecol. 2023. PMID: 37204769. doi:10.1002/uog.26253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。